Spots Global Cancer Trial Database for acute leukemia in remission
Every month we try and update this database with for acute leukemia in remission cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation | NCT03842696 | Hematologic Dis... Acute Leukemia ... Chronic Myeloge... Chronic Myeloge... Chronic Myeloge... Myelodysplastic... Mantle Cell Lym... Follicular Lymp... Diffuse Large B... Non Hodgkin Lym... Graft Vs Host D... Graft-versus-ho... | Vorinostat Blood and Marro... Tacrolimus (or ... Methotrexate Mycophenolate M... Cyclophosphamid... | 3 Years - 39 Years | University of Michigan Rogel Cancer Center | |
Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell Transplants | NCT01488253 | Acute Leukemia ... Myelodysplastic... Leukemia, Myelo... Leukemia, Myelo... | Sirolimus Tacrolimus | 20 Years - 60 Years | The Korean Society of Blood and Marrow Transplantation | |
VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies | NCT03885947 | Hematological M... Acute Leukemia ... Acute Lymphobla... Myelodysplastic... Non-Hodgkin Lym... Hodgkin Lymphom... | Cord blood stem... Valproic Acid Fludarabine cytoxan Thiotepa TBI | 18 Years - 65 Years | Icahn School of Medicine at Mount Sinai | |
A Study Comparing Single Versus Double Umbilical Cord Blood Transplantation in the Young With Acute Leukemia Remission | NCT01067300 | Leukemia | Transplantation... | - 35 Years | Assistance Publique Hopitaux De Marseille | |
Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL | NCT04846439 | Platelet Transf... Acute Leukemia ... | CAR-T infusion | 16 Years - 65 Years | The First Affiliated Hospital of Soochow University | |
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation | NCT03842696 | Hematologic Dis... Acute Leukemia ... Chronic Myeloge... Chronic Myeloge... Chronic Myeloge... Myelodysplastic... Mantle Cell Lym... Follicular Lymp... Diffuse Large B... Non Hodgkin Lym... Graft Vs Host D... Graft-versus-ho... | Vorinostat Blood and Marro... Tacrolimus (or ... Methotrexate Mycophenolate M... Cyclophosphamid... | 3 Years - 39 Years | University of Michigan Rogel Cancer Center | |
Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL | NCT04846439 | Platelet Transf... Acute Leukemia ... | CAR-T infusion | 16 Years - 65 Years | The First Affiliated Hospital of Soochow University | |
Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation | NCT04935684 | Acute Leukemia ... Myelodysplastic... Myeloproliferat... Hodgkin Lymphom... Lymphoma, Non-H... Myeloma Chronic Lymphoc... | Fecal Microbiot... | 18 Years - | University Hospital, Clermont-Ferrand |